Benjamin Young

Summary

Country: USA

Publications

  1. ncbi Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study
    Benjamin Young
    Denver Infectious Disease Consultants, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 23:589-92. 2009
  2. ncbi First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America
    Benjamin Young
    Division of General Internal Medicine, University of Colorado, Rose Medical Center, Denver, Colorado 80220, USA
    AIDS 22:1673-5. 2008
  3. ncbi Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, Colorado 80220, USA
    Clin Infect Dis 52:1061-8. 2011
  4. ncbi Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study
    Kenneth A Lichtenstein
    National Jewish Medical and Research Center, Denver, Colorado 80206, USA
    Clin Infect Dis 51:435-47. 2010
  5. ncbi Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Int Assoc Physicians AIDS Care (Chic) 6:178-87. 2007
  6. ncbi Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    AIDS Patient Care STDS 20:238-44. 2006
  7. ncbi The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 37:S13-20. 2004
  8. ncbi Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, CO, USA
    Antivir Ther 16:253-6. 2011
  9. ncbi Review: mixing new cocktails: drug interactions in antiretroviral regimens
    Benjamin Young
    Rose Medical Center, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 19:286-97. 2005
  10. ncbi PA update: DHHS guidelines for the treatment of HIV infection
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    JAAPA . 2006

Collaborators

Detail Information

Publications18

  1. ncbi Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study
    Benjamin Young
    Denver Infectious Disease Consultants, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 23:589-92. 2009
    ....
  2. ncbi First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America
    Benjamin Young
    Division of General Internal Medicine, University of Colorado, Rose Medical Center, Denver, Colorado 80220, USA
    AIDS 22:1673-5. 2008
    ....
  3. ncbi Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, Colorado 80220, USA
    Clin Infect Dis 52:1061-8. 2011
    ..Among persons with HIV infection, low bone mineral density is common and has raised concerns about increased risk of fracture...
  4. ncbi Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study
    Kenneth A Lichtenstein
    National Jewish Medical and Research Center, Denver, Colorado 80206, USA
    Clin Infect Dis 51:435-47. 2010
    ..We investigated the association of low CD4(+) T lymphocyte cell count with incident CVD in a cohort of outpatients treated in 10 HIV specialty clinics in the United States...
  5. ncbi Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Int Assoc Physicians AIDS Care (Chic) 6:178-87. 2007
    ..Conclusions: In this large cohort of HIV-infected outpatients, use of TDF-containing HAART was associated with modest decreases in CrCl during the first year, but not with frequent, clinically significant renal toxicity...
  6. ncbi Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    AIDS Patient Care STDS 20:238-44. 2006
    ....
  7. ncbi The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 37:S13-20. 2004
    ..In an environment where several NRTI/NtRTI backbones offer comparable efficacy, treatment decisions will increasingly be made based on toxicity, resistance, and convenience considerations...
  8. ncbi Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, CO, USA
    Antivir Ther 16:253-6. 2011
    ..This case illustrates an emerging need to consider the possibility of acquired INI resistance among newly diagnosed treatment-naive individuals harbouring multidrug-resistant HIV-1...
  9. ncbi Review: mixing new cocktails: drug interactions in antiretroviral regimens
    Benjamin Young
    Rose Medical Center, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 19:286-97. 2005
    ..The paper also addresses interactions between these antiretrovirals and other commonly used medications that may be prescribed concomitantly...
  10. ncbi PA update: DHHS guidelines for the treatment of HIV infection
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    JAAPA . 2006
  11. ncbi Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 31:478-82. 2002
    ..In this study, twice-daily indinavir 800 mg/ritonavir 100 mg with two nucleoside reverse transcriptase inhibitors provided potent viral suppression and immunologic reconstitution in many PI-naive patients...
  12. ncbi Use of screening colonoscopy in ambulatory HIV-infected patients
    Jeffrey Campbell
    Rose Medical Center, University of Colorado, General Internal Medicine, Boulder, Colorado, USA
    J Int Assoc Physicians AIDS Care (Chic) 7:286-8. 2008
    ..Colorectal cancer screenings are underused in HIV-infected patients, but reasons for underuse have not been examined...
  13. ncbi Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 22:1345-54. 2008
    ..To assess temporal trends in the rates of hospitalizations and associated diagnoses among HIV-infected patients before and during the era of highly active antiretroviral therapy...
  14. ncbi Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003
    Pragna Patel
    Centers for Disease Control and Prevention, Emory University, and Northrop Grumman Information Technology, Atlanta, Georgia 30333, USA
    Ann Intern Med 148:728-36. 2008
    ..Persons who are HIV-infected may be at higher risk for certain types of cancer than the general population...
  15. ncbi Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects
    Joel E Gallant
    Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Infect Dis 192:1921-30. 2005
    ..Antiretroviral combinations that reduce the number of pills and dosing frequency have the potential to simplify therapy. We compared 2 regimens dosed as 2 pills once daily...
  16. ncbi The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
    Joseph Eron
    Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC 27599, USA
    Lancet 368:476-82. 2006
    ..INTERPRETATION: Fosamprenavir-ritonavir twice daily in treatment-naive patients provides similar antiviral efficacy, safety, tolerability, and emergence of resistance as lopinavir-ritonavir, each in combination with abacavir-lamivudine...
  17. ncbi Fragility fractures in HIV-infected patients: need for better understanding of diagnosis and management
    Grace A McComsey
    Case Western Reserve University, Cleveland, OH, USA
    J Int Assoc Physicians AIDS Care (Chic) 3:86-91. 2004
    ..In HIV and ART, osteopenia and osteoporosis are multifactorial, and health promotion or medical health maintenance should anticipate and prevent morbidity of bone fragility fractures...
  18. ncbi Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort
    Kate Buchacz
    J Acquir Immune Defic Syndr 43:626-8. 2006